tradingkey.logo
tradingkey.logo
Search

Maze Therapeutics Inc

MAZE
Add to Watchlist
24.580USD
-1.790-6.79%
Close 09-09 16:00ET
1.37BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-6.79%

5 Days

-8.01%

1 Month

-14.21%

6 Months

-45.45%

Year to Date

-40.67%

1 Year

+50.43%

Key Figures

25.860Open
26.545High
32.16KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
26.370Prev. Close
24.390Low
803.39KTurnover
401.17P/E Static
3.02P/B
0.00%Div Yield TTM
-32.57%ROA
53.65052wk High
0.09Volume Ratio
3.40MNet Profit
55.50MShares
-2.3549EPS TTM
--Beta
-38.67%ROE
20.00052wk Low
7.58%Amplitude
100.00%Gross Margin
1.37BMarket Cap
-1.16Reward/Risk
5.23%Risk Rate
More news coming soon, stay tuned...

Maze Therapeutics Inc's Score

0.27vs previous score
Forecast8.83
Financial Health9.20
Technical4.99
Valuation Dimensions8.05
Institutional Confidence10.00
Risk Assessment5.77

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
63.500Target Price
+142.27%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy55555555
Buy77775443
Hold00000000
Sell00000000
Strong Sell00000000

Maze Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Strong sell

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.76/-0.73
Revenue / Forecast
0.00/2.00M

Maze Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolMAZE
Number of employees125
CountryUnited States of America

Ownership

ShareholdersProportion
Third Rock Ventures, LLC9.80%
Frazier Life Sciences Management, L.P.8.25%
Deep Track Capital LP7.67%
ARCH Venture Partners7.44%
Shareholder TypesProportion
Venture Capital29.53%
Hedge Fund22.51%
Investment Advisor/Hedge Fund17.37%
Investment Advisor14.65%

FAQs

What is the current price of Maze Therapeutics Inc (MAZE)?

The current price of Maze Therapeutics Inc (MAZE) is 24.58.

What is the symbol of Maze Therapeutics Inc?

The ticker symbol of Maze Therapeutics Inc is MAZE.

What is the 52-week high of Maze Therapeutics Inc?

The 52-week high of Maze Therapeutics Inc is 53.65.

What is the 52-week low of Maze Therapeutics Inc?

The 52-week low of Maze Therapeutics Inc is 20.00.

What is the market capitalization of Maze Therapeutics Inc?

The market capitalization of Maze Therapeutics Inc is 1.37B.

Is Maze Therapeutics Inc (MAZE) currently rated as Buy, Hold, or Sell?

According to analysts, Maze Therapeutics Inc (MAZE) has an overall rating of Buy, with a price target of 63.50.

What is the Earnings Per Share (EPS TTM) of Maze Therapeutics Inc (MAZE)?

The Earnings Per Share (EPS TTM) of Maze Therapeutics Inc (MAZE) is -2.35.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.